Morphine Oral Concentrate (20 mg/mL) and Moxetumomab pasudotox
Determining the interaction of Morphine Oral Concentrate (20 mg/mL) and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Oral Concentrate (20 mg/mL)-Moxetumomab Pasudotox-tdfk
- Morphine Oral Concentrate (20 mg/mL)-Moxetumomab pasudotox-tdfk Intravenous
- Morphine Oral Concentrate (20 mg/mL)-Moxifloxacin
- Morphine Oral Concentrate (20 mg/mL)-Moxifloxacin (Systemic)
- Morphine Oral Concentrate (20 mg/mL)-Moxifloxacin Hydrochloride
- Morphine Oral Concentrate (20 mg/mL)-Moxifloxacin Injection
- Moxetumomab pasudotox-Morphine Oral Solution
- Moxetumomab pasudotox-Morphine Sulfate
- Moxetumomab pasudotox-Morphine Sulfate Injection
- Moxetumomab pasudotox-Morphine Sulfate Injection, Concentrate
- Moxetumomab pasudotox-Morphine Sulfate Solution, Concentrate
- Moxetumomab pasudotox-Morphine Sulfate Suppository